These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33830701)

  • 81. Subjective Feelings of Polish Doctors after Receiving the COVID-19 Vaccine.
    Zdziarski K; Landowski M; Zabielska P; Karakiewicz B
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34200710
    [TBL] [Abstract][Full Text] [Related]  

  • 82. PEG skin testing for COVID-19 vaccine allergy.
    Stone BD
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1765. PubMed ID: 33838847
    [No Abstract]   [Full Text] [Related]  

  • 83. The Global Interest in Vaccines and Its Prediction and Perspectives in the Era of COVID-19. Real-Time Surveillance Using Google Trends.
    Sycinska-Dziarnowska M; Paradowska-Stankiewicz I; Woźniak K
    Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360134
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Palms and soles itchiness as a side effect of COVID-19 vaccination.
    Al-Ansari RY; Al-Sharari M; Al-Saadi T
    J Infect Public Health; 2021 Oct; 14(10):1389-1391. PubMed ID: 34391695
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management.
    Luxi N; Giovanazzi A; Arcolaci A; Bonadonna P; Crivellaro MA; Cutroneo PM; Ferrajolo C; Furci F; Guidolin L; Moretti U; Olivieri E; Petrelli G; Zanoni G; Senna G; Trifirò G
    BioDrugs; 2022 Jul; 36(4):443-458. PubMed ID: 35696066
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Ontological Analysis of COVID-19 Vaccine Roll out Strategies: A Comparison of India and the United States of America.
    Sreeganga SD; Chandra A; Ramaprasad A
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299929
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Gene therapies and COVID-19 vaccines: a necessary discussion in relation with viral vector-based approaches.
    Aledo-Serrano A; Gil-Nagel A; Isla J; Mingorance A; Mendez-Hermida F; Hernandez-Alcoceba R
    Orphanet J Rare Dis; 2021 Jul; 16(1):316. PubMed ID: 34271959
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient.
    Hill JA; Ujjani CS; Greninger AL; Shadman M; Gopal AK
    Cancer Cell; 2021 Aug; 39(8):1037-1038. PubMed ID: 34242571
    [No Abstract]   [Full Text] [Related]  

  • 89. Double standards redux.
    Macklin R
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908355
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Vaccination in the context of the COVID-19 pandemic.
    Díaz-Badillo Á; Garibay-Nieto GN; Navas-Figueroa AL; Perales-Torres AL; Morales-Gómez MC; López-Alvarenga JC
    Cir Cir; 2021; 89(6):836-843. PubMed ID: 34851594
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Spotlight on Vaccines: Pandemic May Open Gateway to Improve Vaccination Rates in Texas.
    Price S
    Tex Med; 2021 Mar; 117(3):20-25. PubMed ID: 34855954
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Development and outlook on human challenge trial of vaccine].
    Han BF; Huang NH; Chen LY; Zhao TS; Liu HY; Zhang SH; Wang Y; Zheng H; Liu B; Wang C; Liu YQ; Lu QB; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Aug; 42(8):1371-1375. PubMed ID: 34814556
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Novel strategies to support global promotion of COVID-19 vaccination.
    Wood S; Pate MA; Schulman K
    BMJ Glob Health; 2021 Oct; 6(10):. PubMed ID: 34649869
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Do Corticosteroid Injections for the Treatment of Pain Influence the Efficacy of Adenovirus Vector-Based COVID-19 Vaccines?
    Lee H; Punt JA; Patel J; Stojanovic MP; Duszynski B; McCormick ZL;
    Pain Med; 2021 Jun; 22(6):1441-1464. PubMed ID: 33839780
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The power of choice: Experimental evidence that freedom to choose a vaccine against COVID-19 improves willingness to be vaccinated.
    Sprengholz P; Eitze S; Korn L; Siegers R; Betsch C
    Eur J Intern Med; 2021 May; 87():106-108. PubMed ID: 33810941
    [No Abstract]   [Full Text] [Related]  

  • 96. Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines.
    Palomares F; Paris JL; Labella M; Doña I; Mayorga C; Torres MJ
    Allergy; 2022 Dec; 77(12):3527-3537. PubMed ID: 35912413
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The Use of GIS Technology to Optimize COVID-19 Vaccine Distribution: A Case Study of the City of Warsaw, Poland.
    Krzysztofowicz S; Osińska-Skotak K
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34070378
    [TBL] [Abstract][Full Text] [Related]  

  • 98. COVID-19 vaccines: What dermatologists should know?
    Ayatollahi A; Hosseini H; Firooz R; Firooz A
    Dermatol Ther; 2021 Sep; 34(5):e15056. PubMed ID: 34232548
    [TBL] [Abstract][Full Text] [Related]  

  • 99. PEG/Polysorbate Skin Testing Has No Utility in the Assessment of Suspected Allergic Reactions to SARS-CoV-2 Vaccines.
    Greenhawt M; Shaker M; Golden DBK
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3321-3322. PubMed ID: 34393075
    [No Abstract]   [Full Text] [Related]  

  • 100. Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab.
    Waldman RA; Creed M; Sharp K; Adalsteinsson J; Imitola J; Durso T; Lu J
    J Am Acad Dermatol; 2021 Apr; 84(4):e197-e198. PubMed ID: 33130180
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.